Evidence map›Paper›PMID 34302592›Full record

ArticleApplied biochemistry and biotechnology2021

Apoptosis Induction in Murine Melanoma (B16F10) Cells by Mannosylerythritol Lipids-B; a Glycolipid Biosurfactant with Antitumoral Activities.

P E Feuser, A L S Coelho, M E de Melo, R Scussel, B A M Carciofi, R A Machado-de-Ávila, D de Oliveira, C J de Andrade

Abstract read
PubMed Publisher
In one paragraph

Article in Applied biochemistry and biotechnology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Biomolecules · 2026
    Article
  3. Article
  4. Review
  5. Review
  6. Application of Biosurfactants in Medical Sciences.Molecules (Basel, Switzerland) · 2024
    Review
  7. Review
  8. Effects of Mannosylerythritol-Lipids-B onIndian journal of microbiology · 2024
    Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

P E FeuserGraduate Program in Chemical Engineering, Department of Chemical and Food Engineering, Federal University of Santa Catarina, Trindade, s/n, Florianópolis, Santa Catarina, 88040-900, Brazil.ORCID https://orcid.org/0000-0003-2372-8945
A L S CoelhoGraduate Program in Food Engineering, Department of Chemical and Food Engineering, Federal University of Santa Catarina, Trindade, s/n, Florianópolis, Santa Catarina, 88040-900, Brazil.ORCID https://orcid.org/0000-0001-6370-0782
M E de MeloGraduate Program in Health Science, University of the Extreme South Santa Catarina, Criciúma, Santa Catarina, Brazil.ORCID https://orcid.org/0000-0003-0205-2966
R ScusselGraduate Program in Health Science, University of the Extreme South Santa Catarina, Criciúma, Santa Catarina, Brazil.ORCID http://orcid.org/0000-0002-0931-604X
B A M CarciofiGraduate Program in Food Engineering, Department of Chemical and Food Engineering, Federal University of Santa Catarina, Trindade, s/n, Florianópolis, Santa Catarina, 88040-900, Brazil.ORCID https://orcid.org/0000-0002-9233-0984
R A Machado-de-ÁvilaGraduate Program in Health Science, University of the Extreme South Santa Catarina, Criciúma, Santa Catarina, Brazil.ORCID https://orcid.org/0000-0002-1303-0490
D de OliveiraGraduate Program in Chemical Engineering, Department of Chemical and Food Engineering, Federal University of Santa Catarina, Trindade, s/n, Florianópolis, Santa Catarina, 88040-900, Brazil.ORCID https://orcid.org/0000-0003-0151-5172
C J de AndradeGraduate Program in Chemical Engineering, Department of Chemical and Food Engineering, Federal University of Santa Catarina, Trindade, s/n, Florianópolis, Santa Catarina, 88040-900, Brazil. eng.crisja@gmail.com.ORCID http://orcid.org/0000-0001-7544-5045
Universidade Federal de Santa Catarina · BRUniversidade do Extremo Sul Catarinense · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mannosylerythritol lipids have drawn attention to cosmetic and pharmaceutical industries due to their non-toxicity and excellent biological interactions with human skin, particularly with the deepest epidermal layer. Lamellar liquid crystal structure, formed by MEL-B, is an interesting feature due to its similarity to the stratum corneum molecular arrangement and cell signaling events involved in the deregulation of the cancerous cell membrane. Thus, this work aimed to evaluate the cytotoxicity of commercial mannosylerythritol lipids-B in murine melanoma, fibroblast, and human erythrocytes cells. Cytotoxic effect was more pronounced on the tumor cells from 20 µg/mL, reducing cell viability by 65%, whereas fibroblast and human erythrocytes cells were more resistant to glycolipid treatment. Fluorescence microscopy and flow cytometer proved that mannosylerythritol lipids-B is an apoptosis inducer in tumor cells related to reactive oxygen species generation.

Indexed as

Antineoplastic AgentsCytotoxinsGlycolipidsMelanoma, ExperimentalSurface-Active AgentsAnimalsApoptosisMiceAntineoplastic AgentsCytotoxinsGlycolipidsmannosylerythritol lipidSurface-Active Agents

Identifiers

PMID34302592
OpenAlexW3185303149

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.